Although further analyses are required to determine the underlying mechanism for TGFβ/SMAD3 signaling-induced apoptosis in NSCLC, our results established an interplay between USP7 and TGFβ/SMAD3 signaling in regulating cancer cell progression in p53-null NSCLC cells. The gene discussed is TP53; the disease is cancer.